相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid Ligands Targeting TRP Channels
Chante Muller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol
Antonella Smeriglio et al.
FITOTERAPIA (2018)
Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods
Dvory Namdar et al.
INDUSTRIAL CROPS AND PRODUCTS (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats
Daniel I. Brierley et al.
PSYCHOPHARMACOLOGY (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Torsten Lowin et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The effect of cannabichromene on adult neural stem/progenitor cells
Noriko Shinjyo et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
Jonathan A. Farrimond et al.
PSYCHOPHARMACOLOGY (2012)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
New Cannabinoid-Like Chromane and Chromene Derivatives from Rhododendron anthopogonoides
Naoki Iwata et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa)
Federica Pollastro et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha(2)-adrenoceptor agonist and moderately potent 5HT(1A) receptor antagonist
M. G. Cascio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol
Gerald T. DeLong et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
Dean F. Wong et al.
NEUROIMAGE (2010)
The inheritance of chemical phenotype in Cannabis sativa L. (III): variation in cannabichromene proportion
E. P. M. de Meijer et al.
EUPHYTICA (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Antibacterial cannabinoids from Cannabis sativa:: A structure-activity study
Giovanni Appendino et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L
D. Pacifico et al.
EUPHYTICA (2008)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The inheritance of chemical phenotype in Cannabis sativa L. (II):: Cannabigerol predominant plants
EPM de Meijer et al.
EUPHYTICA (2005)
A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)
KW Hillig et al.
AMERICAN JOURNAL OF BOTANY (2004)
分享论文
